Journal Article DZNE-2026-00949

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Autoantibodies targeting G protein-coupled receptors and clinical outcome after ischemic stroke (PROSCIS-B).

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Steinkopff [Darmstadt]

Journal of neurology 273(10), 581 () [10.1007/s00415-026-14103-6]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: G protein-coupled receptor (GPCR) directed regulatory autoantibodies (RABs) have previously been linked to poor functional outcome after ischemic stroke. We investigated the impact of anti-α1/α2/β1/β2 receptor, endothelin B receptor, angiotensin II receptor type 2, and CXCR3 receptor directed RABs on functional outcome and recurrent events after ischemic stroke.Data were derived from the Prospective Cohort with Incident Stroke Berlin (PROSCIS-B; NCT01363856). RABs were measured by ELISA (CellTrend) from sera collected within seven days of first-ever stroke. High RAB levels (quartile [Q]4 vs. Q1-3) and low levels (Q1 vs. Q2-4) were compared to reference groups. Quartile subgroups were characterized at baseline. Functional outcome, measured by the Modified Rankin Scale (mRS) at one year, was evaluated with ordinal logistic regression. Cox proportional hazard models were used to assess risk for a combined endpoint (stroke, myocardial infarction, death) over three years.562 patients were included (mean age 67 (SD= 13); 38% female). All RABs showed more large artery atherosclerosis (LAA) stroke in Q1, while cardioembolic strokes (CE) were more frequent in Q4. Worse functional outcome at 12 months was associated with high levels (Q4) of alpha2-antibodies (abs) (OR=1.49; 95%CI=1.02-2.18) and ETB-abs (OR=1.49; 95%CI=1.02-2.18) vs. Q1-Q3. Recurrent cardiovascular risk over three years was higher with low levels (Q1) of AT2-abs (HR=1.86; 95%CI=1.22-2.86), alpha2-abs (HR=1.77; 95%CI=1.15-2.72), and beta1-abs (HR=1.58; 95%CI=1.03-2.44) vs. Q2-Q4.Differential associations of low vs. high levels of several RABs with stroke etiology, functional outcome, and recurrent vascular risk suggest potential roles in stroke pathophysiology.

Keyword(s): Humans (MeSH) ; Female (MeSH) ; Autoantibodies: blood (MeSH) ; Ischemic Stroke: blood (MeSH) ; Ischemic Stroke: immunology (MeSH) ; Ischemic Stroke: epidemiology (MeSH) ; Male (MeSH) ; Aged (MeSH) ; Receptors, G-Protein-Coupled: immunology (MeSH) ; Middle Aged (MeSH) ; Prospective Studies (MeSH) ; Brain Ischemia: blood (MeSH) ; Brain Ischemia: immunology (MeSH) ; Stroke: blood (MeSH) ; Autoantibodies ; Epidemiology ; G protein-coupled receptors ; Ischemia ; Stroke ; Autoantibodies ; Receptors, G-Protein-Coupled

Classification:

Contributing Institute(s):
  1. Interdisciplinary Dementia Research (AG Endres)
  2. Autoimmune Encephalopathies (AG Prüß)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > B DZNE > B DZNE-AG Prüß
Institute Collections > B DZNE > B DZNE-AG Endres
Documents in Process
Public records
In process

 Record created 2026-09-11, last modified 2026-09-11


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)